Adtalem Global Education (NYSE:CVSA) CEO Stephen Beard Sells 2,762 Shares of Stock

Adtalem Global Education Inc. (NYSE:CVSA) CEO Stephen Beard sold 2,762 shares of the company’s stock in a transaction that occurred on Wednesday, June 10th. The shares were sold at an average price of $130.14, for a total value of $359,446.68. Following the transaction, the chief executive officer directly owned 426,562 shares in the company, valued at approximately $55,512,778.68. This represents a 0.64% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Stock Performance

CVSA opened at $128.23 on Friday. The company has a market capitalization of $4.36 billion, a PE ratio of 19.97, a price-to-earnings-growth ratio of 1.09 and a beta of 0.62. The company’s 50 day simple moving average is $120.70. Adtalem Global Education Inc. has a one year low of $86.97 and a one year high of $156.26. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.70 and a current ratio of 0.70.

Adtalem Global Education (NYSE:CVSA) last released its earnings results on Thursday, May 7th. The company reported $1.98 EPS for the quarter, beating analysts’ consensus estimates of $1.73 by $0.25. The firm had revenue of $487.03 million for the quarter. Adtalem Global Education had a return on equity of 20.19% and a net margin of 12.26%.The company’s quarterly revenue was up 4.5% compared to the same quarter last year. During the same period in the prior year, the company posted $1.92 EPS. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. As a group, analysts predict that Adtalem Global Education Inc. will post 8.04 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of brokerages recently issued reports on CVSA. Barrington Research reiterated an “outperform” rating and issued a $170.00 price target on shares of Adtalem Global Education in a report on Monday, June 8th. Zacks Research lowered Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a report on Wednesday, March 25th. Wall Street Zen upgraded Adtalem Global Education from a “hold” rating to a “buy” rating in a report on Saturday. Weiss Ratings reiterated a “hold (c+)” rating on shares of Adtalem Global Education in a report on Friday, May 22nd. Finally, Truist Financial boosted their price target on Adtalem Global Education from $130.00 to $140.00 and gave the company a “buy” rating in a report on Monday, May 11th. Two equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $155.00.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.